Navigation Links
Olanzapine Long-Acting Injection (LAI) Data Presented at First Annual Schizophrenia International Research Society Conference
Date:6/22/2008

s, patients with schizophrenia are at greater risk for medical comorbidities than the general population.

About Olanzapine

Olanzapine is indicated in the United States for the treatment of schizophrenia, acute mixed and manic episodes of bipolar disorder, and maintenance treatment of bipolar disorder. In Europe, olanzapine is indicated for the treatment of schizophrenia and olanzapine is effective in maintaining the clinical improvement during continuation therapy in patients who have shown an initial treatment response. Olanzapine is also indicated in patients whose manic episode has responded to olanzapine treatment and it is indicated for the prevention of recurrence in patients with bipolar disorder.

Since olanzapine was introduced in 1996, it has been prescribed to approximately 24 million people worldwide. Olanzapine is not approved for patients under 18 years of age.

Hyperglycemia, in some cases extreme and associated with ketoacidosis or hyperosmolar coma or death, has been reported in patients treated with atypical antipsychotics, including olanzapine. While relative risk estimates are inconsistent, the association between atypical antipsychotics and increases in glucose levels appears to fall on a continuum and olanzapine appears to have a greater association than some other atypical antipsychotics. Physicians should consider the risks and benefits when prescribing olanzapine to patients with an established diagnosis of diabetes mellitus, or who have borderline increased blood glucose level. Patients taking olanzapine should be monitored regularly for worsening of glucose control. Persons with risk factors for diabetes who are starting on atypical antipsychotics should undergo baseline and periodic fasting blood glucose testing. Patients who develop symptoms of hyperglycemia during treatment should undergo fasting blood glucose testing.

Undesirable alterations in lipids have been observed with olanzapine use. Clinical mon
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Forest and Almirall Announce Positive Results of Clinical Studies for Aclidinium Bromide, a Novel, Long-Acting Anticholinergic for the Treatment for COPD
2. Patients Treated with Risperidone Long-Acting Injection had a Significantly Longer Time to Relapse Compared to Quetiapine in International Clinical Study
3. FDA Advisory Committee Supports Efficacy and Safety of Zyprexa(R) Long-Acting Injection (LAI) for Schizophrenia Treatment
4. New Diabetes Compound AVE0010 Showed Clear Dose Response Results With Once-A-Day Injection in Phase IIb Study
5. Monotherapy BYETTA(R) (exenatide) Injection Study Results Presented at ADA 2008 Showed Adults with Type 2 Diabetes Experienced Improved Glycemic Control and Weight Loss
6. Multiple Clinical Trials of VELCADE(R) (Bortezomib) for Injection Based Therapies Demonstrate High Complete Remission Rates in Patients with Newly Diagnosed Multiple Myeloma
7. VELCADE(R) (Bortezomib) for Injection Based Treatment Delivers Impressive Complete Response and Survival in Patients With Newly Diagnosed Multiple Myeloma
8. New Eloxatin(R) (oxaliplatin injection) Prescribing Information in the U.S. Includes Six-Year Overall Survival Data
9. Ikaria Completes Dosing of Phase 1a Clinical Study for IK-1001 (Sodium Sulfide) for Injection
10. New Data Support High Complete Remission Rates With VELCADE(R) (Bortezomib) for Injection Based Therapies in Patients With Newly Diagnosed Multiple Myeloma
11. CorMatrix(R) Announces Intramyocardial Injection of Emulsified ECM Technology(TM) Demonstrates Enhanced Angiogenesis and Improved Cardiac Function in a Preclinical Model
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/28/2014)... 2014 HK$,000Six months endedChange %  30 September 201430 September 2013Turnover ... Storage Service Income , 384,242 , 339,113 ... , 41,377 , 49.5 Medical Insurance Administration ... 6.4 Medical Devices and Accessories Sales , 94,580 ... Sales , 2,917 , 9,219 , ...
(Date:11/27/2014)... November 27, 2014 Hovione announced ... (IND) Application with the U.S. Food and Drug Administration ... of developing improved drug delivery options for established drugs. ... a novel formulation using a new patented crystalline base ... most widely prescribed oral antibiotics for acne. Currently, there ...
(Date:11/26/2014)... , Nov. 26, 2014  Thoratec Corporation (NASDAQ: ... mechanical circulatory support therapies to save, support and restore ... two upcoming investor conferences. On Tuesday, December ... Annual Piper Jaffray Healthcare Conference.  D. Keith ... an update on the company beginning at 11:30 a.m., ...
Breaking Medicine Technology:Golden Meditech Announces 2014 / 2015 Interim Results 2Golden Meditech Announces 2014 / 2015 Interim Results 3Golden Meditech Announces 2014 / 2015 Interim Results 4Golden Meditech Announces 2014 / 2015 Interim Results 5Golden Meditech Announces 2014 / 2015 Interim Results 6Golden Meditech Announces 2014 / 2015 Interim Results 7Golden Meditech Announces 2014 / 2015 Interim Results 8Hovione Files its First Investigational New Drug Application With the FDA 2Thoratec Announces Presentations At Investor Conferences For December 2014 2
... Mylan Inc. (Nasdaq: MYL ) today ... Laboratories Limited) has received tentative approval from the U.S. ... Drug Application (ANDA) for Atorvastatin Calcium Tablets, 10 mg ... mg (base). Atorvastatin Calcium is the generic equivalent to ...
... HAYWARD, Calif., Feb. 1, 2012   Delphon Industries today ... International Test Solutions, the world leader in probe ... ProbeMax products to enhance their existing probe cleaning ... with Complete Probe Solutions, who was the exclusive ...
Cached Medicine Technology:
(Date:11/28/2014)... (PRWEB) November 28, 2014 Written and narrated ... Brook Forest Voices releases the “The Happiest Man In ... a compelling account of how and why Project C.U.R.E. came ... by his mother Josie and the Reverend Richard W. Jackson, ... the age of 30, but realized that he wasn’t happy. ...
(Date:11/28/2014)... (HealthDay News) -- Planning on seconds at Thanksgiving Day ... clinically known as gastroesophageal reflux disease (GERD) -- a few ... an ear, nose and throat specialist at Lenox Hill Hospital ... manage GERD on Thanksgiving: Pace yourself. ... small meals throughout the day. It,s also a good idea ...
(Date:11/28/2014)... Not only is the Éminence Organic Skin Care ... and other cancer-causing agents, but they are also proud ... programs that help in the fight against breast cancer. ... incredible, record-breaking contribution of $30,000 through participation in the ... Red Rose Whip Moisturizer and the company’s corporate donation. ...
(Date:11/28/2014)... An inventor and dental assistant from Kent, ... filling and it was almost impossible to reach. "This gave ... said. , The patent-pending Access Light allows for easier use ... of the mouth, as well as avoids harm to the ... to use and clean, it also helps prevent cross-contamination. , ...
(Date:11/28/2014)... Canada (PRWEB) November 28, 2014 ... the stuff kids lose® and an award-winning company established ... Julie Ellis, Cynthia Esp, and Tricia Mumby have been ... They were recognized with the PROFIT Award for Excellence ... Ellis, Cynthia Esp, and Tricia Mumby) accepted the award ...
Breaking Medicine News(10 mins):Health News:Thanksgiving Weekend Audiobook Treat! “The Happiest Man In the World: Life Lessons From a Cultural Economist” by Dr. James W. Jackson 2Health News:Don't Let Chronic Heartburn Spoil Your Thanksgiving Feast 2Health News:Éminence Organic Skin Care Donates Record-breaking $30,000 to Breast Cancer Research 2Health News:Éminence Organic Skin Care Donates Record-breaking $30,000 to Breast Cancer Research 3Health News:Mabel's Labels’ Co-Founders Named A Winner In The 2014 RBC Canadian Women Entrepreneur Awards Program; A Second-Time Win For The Brand 2Health News:Mabel's Labels’ Co-Founders Named A Winner In The 2014 RBC Canadian Women Entrepreneur Awards Program; A Second-Time Win For The Brand 3
... Biogen Idec announced the national launch of the new AVONEX(R) ... people //with multiple sclerosis (MS) as they begin and continue ... of MS worldwide. ,"As a person living with ... nurses play an important role in working closely with patients ...
... An anti-reflux valve developed to help esophageal cancer patients also ... according to a research//. The study, using the anti-reflux ... bile duct, appears in the May issue of Gastrointestinal Endoscopy ... Anti-Reflux Valve,” named after its inventor, was cleared for use ...
... 65 who lacked health insurance for a year has risen from ... of uninsured residents ranged from a low of 13.4 percent in ... ,Lack of health insurance is a particularly acute problem ... highest proportion of uninsured lie east of Interstate 95. ...
... to take its toll and the number of injured soldiers ... have// lost their limbs. ,The Johns Hopkins University ... team has developed a breakthrough prosthetic arm under the Defense ... ,That program is an initiative to produce by 2009 ...
... How your food is cooked may be as important to ... about a new class of toxins that might soon become// ... disorders as trans fats. ,This class of ... the body through the consumption of grilled, fried, or broiled ...
... representatives have looked at the growing need to understand ... staff and managers across the health service. ... and perceptions of digital libraries (sources of non-personal health ... the introduction of new technologies in particular healthcare contexts ...
Cached Medicine News:Health News:Multiple Sclerosis Patients to Benefit With AVONEX(R) Nurse Services Program 2Health News:Cancer Patient’s Life Improved With Anti-reflux Valv 2Health News:Cancer Patient’s Life Improved With Anti-reflux Valv 3Health News:Number of Uninsured in North Carolina on the Rise 2Health News:A Realistic Arm on the Anvil for Injured Soldiers 2Health News:Food Preparation may Play a Bigger Role in Chronic Disease 2Health News:Food Preparation may Play a Bigger Role in Chronic Disease 3Health News:Food Preparation may Play a Bigger Role in Chronic Disease 4
The Soft-Touch Timeter® Flowmeter is durable, long-lasting and easy to maintain. Timeter ® by Allied Flowmeters: Quality Plus Value....
... complete line of flowmeters, available in ... . They are all available in ... suit your application. With color coded ... gas in use, the Amvex Flowmeter ...
The Soft-Touch Timeter® Flowmeter is durable, long-lasting and easy to maintain. Timeter ® by Allied Flowmeters: Quality Plus Value....
... Amvex offers a complete line of ... and CO 2 . They are ... calibrations to best suit your application. ... specific to the gas in use, ...
Medicine Products: